Cargando…

Transcriptional Regulation of the HMGA1 Gene by Octamer-Binding Proteins Oct-1 and Oct-2

The High-Mobility Group AT-Hook 1 (HMGA1) protein is an architectural transcription factor that binds to AT-rich sequences in the promoter region of DNA and functions as a specific cofactor for gene activation. Previously, we demonstrated that HMGA1 is a key regulator of the insulin receptor (INSR)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiefari, Eusebio, Arcidiacono, Biagio, Possidente, Katiuscia, Iiritano, Stefania, Ventura, Valeria, Pandolfo, Rosantony, Brunetti, Francesco Saverio, Greco, Manfredi, Foti, Daniela, Brunetti, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867479/ https://www.ncbi.nlm.nih.gov/pubmed/24367622 http://dx.doi.org/10.1371/journal.pone.0083969

Ejemplares similares

HMGA1 is a novel downstream nuclear target of the insulin receptor signaling pathway
por: Chiefari, Eusebio, et al.
Publicado: (2012)

Insulin Resistance and Cancer Risk: An Overview of the Pathogenetic Mechanisms
por: Arcidiacono, Biagio, et al.
Publicado: (2012)

Cooperation between HMGA1, PDX-1, and MafA is Essential for Glucose-Induced Insulin Transcription in Pancreatic Beta Cells
por: Arcidiacono, Biagio, et al.
Publicado: (2015)

A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components
por: Chiefari, Eusebio, et al.
Publicado: (2013)

Long-term diabetic complications in elderly patients with variable levels of HMGA1 expression
por: Chiefari, E, et al.
Publicado: (2010)

Transcriptional Regulation of Glucose Metabolism: The Emerging Role of the HMGA1 Chromatin Factor
por: Chiefari, Eusebio, et al.
Publicado: (2018)

A novel mechanism of post-translational modulation of HMGA functions by the histone chaperone nucleophosmin
por: Arnoldo, Laura, et al.
Publicado: (2015)

HMGA1 is a novel transcriptional regulator of the FoxO1 gene
por: Arcidiacono, Biagio, et al.
Publicado: (2017)

Cross-talk among HMGA1 and FoxO1 in control of nuclear insulin signaling
por: Chiefari, Eusebio, et al.
Publicado: (2018)

A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expression
por: Chiefari, Eusebio, et al.
Publicado: (2016)

The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis
por: Chiefari, Eusebio, et al.
Publicado: (2009)

Cooperation between HMGA1 and HIF-1 Contributes to Hypoxia-Induced VEGF and Visfatin Gene Expression in 3T3-L1 Adipocytes
por: Messineo, Sebastiano, et al.
Publicado: (2016)

The anticancer effects of Metformin in the male germ tumor SEM-1 cell line are mediated by HMGA1
por: Salatino, Alessandro, et al.
Publicado: (2022)

Predictors of Postpartum Glucose Tolerance Testing in Italian Women with Gestational Diabetes Mellitus
por: Capula, Carmelo, et al.
Publicado: (2013)

The Association between HMGA1 rs146052672 Variant and Type 2 Diabetes: A Transethnic Meta-Analysis
por: Bianco, Aida, et al.
Publicado: (2015)

Gestational Diabetes Mellitus: Screening and Outcomes in Southern Italian Pregnant Women
por: Capula, Carmelo, et al.
Publicado: (2013)

Comment on: Marquez et al. Low-Frequency Variants in HMGA1 Are Not Associated With Type 2 Diabetes Risk. Diabetes 2012;61:524–530
por: Brunetti, Antonio, et al.
Publicado: (2012)

Mediterranean Diet Nutrients to Turn the Tide against Insulin Resistance and Related Diseases
por: Mirabelli, Maria, et al.
Publicado: (2020)

Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes
por: Mirabelli, Maria, et al.
Publicado: (2019)

Positive and negative regulation of the composite octamer motif of the interleukin 2 enhancer by AP-1, Oct-2, and retinoic acid receptor
Publicado: (1994)

Long-Term Effectiveness and Safety of SGLT-2 Inhibitors in an Italian Cohort of Patients with Type 2 Diabetes Mellitus
por: Mirabelli, Maria, et al.
Publicado: (2019)

Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links
por: De Rosa, Salvatore, et al.
Publicado: (2018)

Functional relationship between high mobility group A1 (HMGA1) protein and insulin-like growth factor-binding protein 3 (IGFBP-3) in human chondrocytes
por: Gasparini, Giorgio, et al.
Publicado: (2012)

Insulin and osteocalcin: further evidence for a mutual cross-talk
por: Bilotta, Francesco L., et al.
Publicado: (2017)

Correction to: Insulin and osteocalcin: further evidence for a mutual cross-talk
por: Bilotta, Francesco L., et al.
Publicado: (2017)

Octamer-binding factor 6 (Oct-6/Pou3f1) is induced by interferon and contributes to dsRNA-mediated transcriptional responses
por: Hofmann, Elisabeth, et al.
Publicado: (2010)

MicroRNA-1281 as a Novel Circulating Biomarker in Patients With Diabetic Retinopathy
por: Greco, Marta, et al.
Publicado: (2020)

In silico identification of natural product inhibitors against Octamer-binding transcription factor 4 (Oct4) to impede the mechanism of glioma stem cells
por: Nayak, Chirasmita, et al.
Publicado: (2021)

New Target Genes for the Peroxisome Proliferator-Activated Receptor-γ (PPARγ) Antitumour Activity: Perspectives from the Insulin Receptor
por: Foti, Daniela P., et al.
Publicado: (2009)

Effects of genetic polymorphisms on the OCT1 and OCT2-mediated uptake of ranitidine
por: Meyer, Marleen Julia, et al.
Publicado: (2017)

Molecular basis of polyspecific drug binding and transport by OCT1 and OCT2
por: Suo, Yang, et al.
Publicado: (2023)

Oct-2 forms a complex with Oct-1 on the iNOS promoter and represses transcription by interfering with recruitment of RNA PolII by Oct-1
por: Bentrari, Fatima, et al.
Publicado: (2015)

DNA-dependent conversion of Oct-1 and Oct-2 into transcriptional repressors by Groucho/TLE
por: Malin, Stephen, et al.
Publicado: (2005)

OCT and OCT-A biomarkers in multiple sclerosis - review
por: Bostan, Mihai, et al.
Publicado: (2023)

Expansion of Knowledge on OCT1 Variant Activity In Vitro and In Vivo Using Oct1/2(−/−) Mice
por: Morse, Bridget L., et al.
Publicado: (2021)

Analysis of OCT1, OCT2 and OCT3 gene polymorphisms among Type 2 diabetes mellitus subjects in Indian ethnicity, Malaysia
por: Ghasan Abood Al-Ashoor, Sabah, et al.
Publicado: (2022)

Octamer binding protein 2 (Oct2) regulates PD-L2 gene expression in B-1 cells through lineage-specific activity of a unique, intronic promoter
por: Kaku, Hiroaki, et al.
Publicado: (2009)

Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes
por: Mirabelli, Maria, et al.
Publicado: (2021)

MASTL is enriched in cancerous and pluripotent stem cells and influences OCT1/OCT4 levels
por: Närvä, Elisa, et al.
Publicado: (2022)

Role of OCT1 in hepatocellular carcinoma
por: Li, Jingguo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jonv5b7emagohndloe1hutdfd4